Drug-resistant Tuberculosis in Healthcare Settings
Prevention & Control of Multidrug-resistant (MDR)-Tuberculosis in Healthcare Settings
An effective infection control program requires the early detection of TB and the prompt isolation and treatment of persons with TB. The primary emphasis of the TB infection control plan should be on achieving these three goals. Treating and curing drug-resistant TB is complicated. Inappropriate management can have life-threatening results. Drug-resistant TB should be managed by or in close consultation with an expert in the disease.
See also: Non-resistant Tuberculosis in healthcare settings.
Guidelines
- Treatment of Tuberculosis,
2003
MMWR 2003;52(RR-11) PDF (88 pages / 1.46MB) - Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006
PDF 235KB / 73 pages - Guidelines for Preventing the Transmission of Mycobacterium tuberculosis
in Health-Care Settings 2005.
MMWR 2005; 54(RR-17) PDF(1.80 MB, 147 pages)- List of Major Errata in Order of Importance from the "Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-care Settings, 2005"
September 25, 2006 PDF (127 KB, 18 pages)
- List of Major Errata in Order of Importance from the "Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-care Settings, 2005"
Fact Sheets
Please note: Some of these publications are available for download only as *.pdf files. These files require Adobe Acrobat Reader in order to be viewed. Please review the information on downloading and using Acrobat Reader software.
Date last modified: July 9, 2007
Date last reviewed: July 9, 2007
Content source:
Division of Healthcare
Quality Promotion (DHQP)
National Center for Preparedness, Detection, and Control of Infectious Diseases
Infection Control Topics
- Infection Control Home
- Healthcare-Associated Infections
- Protecting Patients
- Protecting Healthcare Workers
- Infection Control Guidelines
- Infection Control A-Z
- About DHQP
